Indications and uses
• temporarily relieves itching and redness caused by pollen, ragweed, grass, animal hair and dander.
• temporarily relieves itching and redness caused by pollen, ragweed, grass, animal hair and dander.
• Adults and children 6 years of age and older: Instill 1 or 2 drops in the affected eye(s) up to 4 times daily. • Children under 6 years: ask a doctor
Naphazoline HCl (0.02675%)
Pheniramine maleate (0.315%)
Redness reliever
Antihistamine
For external use only
If swallowed, get medical help or contact a Poison Control Center right away. Accidental oral ingestion in infants and children may lead to coma and marked reduction in body temperature.
benzalkonium chloride, boric acid, edetate disodium, hypromellose, purified water, sodium borate, sodium chloride. Hydrochloric acid may be used to adjust pH.
Call: 1-866-767-9161
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 59779-552-15 | 2025-01-23 | C162847 | 48780-1 | ba0f9c33-2276-a910-e053-dadaa90a0b85 | Drug Facts |
| 59779-552-30 | 2025-01-23 | C162847 | 48780-1 | ba0f9c33-2276-a910-e053-dadaa90a0b85 | Drug Facts |
| 59779-552-15 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-2276-a910-e053-dadaa90a0b85 | Drug Facts |
| 59779-552-30 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-2276-a910-e053-dadaa90a0b85 | Drug Facts |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| NAPHAZOLINE HYDROCHLORIDE | ACTIVE INGREDIENT | MZ1131787D | 1 | |
| PHENIRAMINE MALEATE | ACTIVE INGREDIENT | NYW905655B | 1 | |
| NAPHAZOLINE | ACTIVE MOIETY | H231GF11BV | 1 | |
| PHENIRAMINE | ACTIVE MOIETY | 134FM9ZZ6M | 1 | |
| BENZALKONIUM CHLORIDE | INACTIVE INGREDIENT | F5UM2KM3W7 | 1 | |
| BORIC ACID | INACTIVE INGREDIENT | R57ZHV85D4 | 1 | |
| EDETATE SODIUM | INACTIVE INGREDIENT | MP1J8420LU | 1 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | 1 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | 1 | |
| SODIUM BORATE | INACTIVE INGREDIENT | 91MBZ8H3QO | 1 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 59779-552 | 59779-552-15, 59779-552-30 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| NAPHAZOLINE HYDROCHLORIDE | MZ1131787D | ACTIB |
| PHENIRAMINE MALEATE | NYW905655B | ACTIB |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | IACT |
| BORIC ACID | R57ZHV85D4 | IACT |
| EDETATE SODIUM | MP1J8420LU | IACT |
| HYPROMELLOSE, UNSPECIFIED | 3NXW29V3WO | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM BORATE | 91MBZ8H3QO | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
| HYDROCHLORIC ACID | QTT17582CB | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SUSPENSION/ DROPS / AURICULAR (OTIC) | 0.02 %w/v | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | INJECTION, SOLUTION / INTRAVENOUS | 210 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRAMUSCULAR | 1486 mg | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION / INTRAVITREAL | ADJ PH | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / TOPICAL | 0.32 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / AURICULAR (OTIC) | 18 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / PERINEURAL | 648 mg | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SOLUTION / INTRAMUSCULAR | ADJ PH | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / ENDOTRACHEAL | 68 mg | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SUSPENSION / SUBCUTANEOUS | ADJ PH | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION/ DROPS / OPHTHALMIC | 1 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | GEL / OPHTHALMIC | 0.9 %w/v | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SOLUTION / EXTRACORPOREAL | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SOLUTION / TOPICAL | ADJ PH | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | INJECTION / INTRAMUSCULAR | 0.01 %w/v | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | GEL / TOPICAL | 10 mg | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION, SUSPENSION / INTRALESIONAL | ADJ PH | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRAPLEURAL | 226 mg | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | OINTMENT / TOPICAL | NA | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION / INTRASPINAL | ADJ PH | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, EXTENDED RELEASE / ORAL | 1472 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | GEL / RECTAL | 348 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | DROPS / ORAL | NA | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION, SUSPENSION / INTRAVENOUS | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SPONGE / TOPICAL | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SOLUTION/ DROPS / OPHTHALMIC | ADJ PH | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | GEL / OPHTHALMIC | 0.01 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / SUBCUTANEOUS | 0.8 %w/v | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | EMULSION / TOPICAL | 1.3 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER / TOPICAL | NA | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | POWDER, FOR SUSPENSION / ENDOTRACHEAL | ADJ PH | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | LOTION / TOPICAL | 0.1 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / PARENTERAL | 210 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SOLUTION / OPHTHALMIC | 0.9 %w/w | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS | ADJ PH | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRAVENOUS | 0.9 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SYRUP / ORAL | 40 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRACAUDAL | 210 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / INTRATYMPANIC | 2 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / AURICULAR (OTIC) | 18 mg | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION, SOLUTION / INTRACARDIAC | ADJ PH | ||
| SODIUM BORATE | SODIUM BORATE | 91MBZ8H3QO | CREAM / TOPICAL | NA | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | SUSPENSION/ DROPS / AURICULAR (OTIC) | 3 mg | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SOLUTION / INTRAVASCULAR | ADJ PH | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE / ORAL | 1488 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION/ DROPS / AURICULAR (OTIC) | 0 %w/v | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRA-ARTERIAL | ADJ PH | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / EPIDURAL | 0.9 %w/v | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | LIQUID / INTRAMUSCULAR | ADJ PH | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBCUTANEOUS | 1486 mg | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SHAMPOO / TOPICAL | 104 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION / AURICULAR (OTIC) | 0.01 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | DROPS / OPHTHALMIC | 0.08 %w/w | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 0.53 %w/v | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | 1127 mg | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SOLUTION / RESPIRATORY (INHALATION) | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | DROPS / NASAL | 10 ml | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRAVESICAL | 351 mg | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | EMULSION / OPHTHALMIC | 0.02 %w/v |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020065-001 | OPCON-A | NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2c62de0e-11e7-46e7-e063-6294a90a37fd | fd1e7e65-2c34-42ba-96cf-f8a17785fcf7 | 2025-01-23 | Warnings | fd1e7e65-2c34-42ba-96cf-f8a17785fcf7 |
Adverse event summaries are temporarily unavailable. Other product information remains available.